Company intelligence / Profile preview

JT New Century

Huntsville, Alabama, United States

Ownership: Private
Development stage: Other

Overview

New Century Pharmaceuticals is described as an early-stage/biopharmaceutical R&D company developing safer, more efficacious oncology and anti-infective drugs based on detailed crystallographic understanding of ligand binding to human serum albumin and related serum proteins; public sources emphasize technology platforms (Salus and recombinant human serum albumin) rather than disclosed clinical-stage assets, indicating work is at discovery or pre-clinical stage.[1][2][6]

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeProteinRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on JT New Century.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JT New Century.

Explore the full profile